查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
整形外科再生手術產品的市場規模、佔有率和趨勢分析報告：按產品、按最終用途、按用途、按地區和細分趨勢，2023-2030年
市場調查報告書
商品編碼
1321447

整形外科再生手術產品的市場規模、佔有率和趨勢分析報告：按產品、按最終用途、按用途、按地區和細分趨勢，2023-2030年

Orthopedic Regenerative Surgical Products Market Size, Share & Trends Analysis Report By Product (Allografts, Viscosupplements), By End-use (Hospitals, ASCs), By Application, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

整形外科再生手術產品市場的成長與趨勢

Grand View Research 的最新報告顯示，到2030年，全球整形外科再生手術產品市場預計將達到 56.3 億美元。

預計2023年至2030年，該市場將以 4.0%的年複合成長率成長。推動市場成長的主要要素包括老年人口的增加、整形外科治療和手術的便利性以及技術的進步。例如，骨關節炎（一種整形外科疾病）認為是老年人（70 歲及以上）慢性殘疾的主要原因。在 COVID-19 大流行期間，由於醫院和診所的慢性病患者數量減少、行銷和銷售活動暫停、選擇性手術推遲、社交距離和封鎖協議，對產品的需求下降。

例如，由於大流行，Annika Therapeutics 在招募患者參加臨床試驗方面面臨挑戰，這對公司的表現和收入產生了負面影響。然而，隨著疫情後擇期手術的恢復，該公司的業績和業務有所反彈。根據美國美國有約 7,800 萬成年人（佔總人口的 26%）診斷出患有關節炎。關節炎的風險隨著年齡的成長而增加，並且在女性中更為常見。另一個危險因子是肥胖。根據美國肥胖盛行率約為 42.4%。因此，整形外科疾病盛行率的增加、人口高齡化和肥胖病例的增加預計將推動市場成長。整形外科再生手術中使用的產品用途範圍廣泛，包括痛風、關節痛、纖維肌痛、關節缺損、骨關節炎、關節重建和創傷。

預計這也將有助於市場成長。市場主要企業採取多項策略性舉措，包括推出新的再生解決方案以緩解疾病疼痛的研發計畫。例如，2021年3月，Amniox Medical, Inc.推出了臨床實驗藥物（IND）TTAX03 - 由臍帶和冷凍羊膜組成，用於緩解小關節骨關節炎的疼痛，已獲得FDA批准投藥測試。Zimmer Biomet 提供廣泛的合成整形外科再生產品和移植物組合，包括 InterGro DBM、PrimaGen Advanced 同種異體移植物和 PlatFORM 可生物吸收骨移植替代品。

整形外科再生手術產品市場報告亮點

  • 由於骨關節炎等整形外科疾病的高盛行率，市場上產品的供應量不斷增加，黏液補充劑細分市場在2022年佔據了最大的市場佔有率，約為42.59%。
  • 由於同種異體移植物的利用率不斷增加，預計同種異體移植物領域在預測期內的年複合成長率為 4.1%。
  • 由於聯合重建中擴大採用再生解決方案，聯合重建領域在2022年佔據用途領域最大的收入佔有率，達到35.66%。
  • 由於老年患者和運動醫學的用途不斷增加，軟骨和肌腱修復領域預計在預測期內將以 4.2%的年複合成長率成長最快。
  • 由於大多數整形外科治療是在醫院進行的，因此醫院最終用途細分市場佔據主導地位，2022年佔據最大收入佔有率，約為 49.04%。
  • 門診手術中心 (ASC) 領域預計在預測期內將呈現 4.1%的最快年複合成長率。
  • 市場主要參與者採取各種策略性舉措，例如產品開發和推出、研究與開發、區域擴張和分銷網路擴張。
  • 2021年 1月，Stryker收購了民營公司OrthoSensor, Inc. 。

目錄

第1章 調查方法與範圍

  • 市場區隔和範圍
  • 調查方法
  • 研究假設
  • 資訊採購
  • 資訊或資料分析
  • 市場形成與檢驗
  • 型號詳情
  • 二手資訊清單

第2章 執行摘要

第3章 整形外科再生手術產品市場變數、趨勢與範圍

  • 市場體系預測
    • 母市場分析
    • 附屬市場預測
  • 整形外科再生手術產品市場動態
    • 市場促進因素分析
    • 市場抑制因素分析
    • 市場機會分析
    • 市場問題分析
  • 2022年採用與成長預測圖
  • 要素因素（政治/法律、經濟/技術）進行 SWOT 分析
    • 政治與法律
    • 經濟形勢
    • 技術形勢
  • 整形外科再生手術產品市場分析工具：Porter
    • 供應商議價能力：低至中等
    • 買方議價能力：中等
    • 替代品的威脅：高
  • 法律規範
    • FDA 考慮因素
    • 償付框架
    • HCPCS編碼
  • 科技趨勢分析
  • 產品平臺分析
  • 骨關節炎的盛行率（2018-2030）

第4章 整形外科再生手術產品市場：COVID-19 的影響分析

  • COVID-19感染疾病的影響分析
    • 疾病盛行率分析
    • 目前影響分析
    • 未來影響分析
    • 對市場參與企業的影響

第5章 整形外科再生手術產品市場：細分分析，依產品，2018-2030

  • 2022年及2030年產品市佔率分析
  • 整形外科再生手術產品市場（分產品），2018-2030
  • 同種異體移植物
  • 合成
  • 基於細胞
  • 黏性補充劑

第6章2018-2030年整形外科再生手術產品市場分析（按用途）（收入）

  • 2022年和2030年用途市佔率分析
  • 整形外科再生手術產品市場（按用途），2018-2030
  • 整形外科疼痛管理
  • 創傷修復
  • 軟骨和肌腱修復
  • 關節重建
  • 其他

第7章 整形外科再生手術產品市場：細分分析，依最終用途，2018-2030

  • 2022年及2030年最終用途市佔率分析
  • 整形外科再生手術產品市場，依最終用途，2018-2030年
  • 醫院
  • 門診手術中心
  • 其他

第8章 整形外科再生手術產品市場：2018-2030年區域市場分析

  • 2022年及2030年區域市佔率分析
  • 區域市場簡介
  • 北美洲
    • 2018年至2030年北美整形外科再生手術產品市場估計與預測
    • 美國
    • 加拿大
  • 歐洲
    • 2018年至2030年歐洲整形外科和再生手術產品市場估計和預測
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
  • 亞太地區
    • 2018年至2030年亞太地區整形外科和再生手術產品市場估計和預測
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
  • 拉丁美洲
    • 拉丁美洲整形外科再生手術產品市場，2018-2030
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東、非洲
    • MEA整形外科再生手術產品市場，2018-2030
    • 南非
    • 沙烏地阿拉伯

第9章 整形外科再生手術產品市場-公司簡介

  • 公司簡介
    • Baxter
    • Zimmer Biomet
    • Stryker
    • Smith+Nephew
    • Allosource
    • Amniox Medical, Inc.
    • Anika Therapeutics, Inc.
    • Vericel Corporation
    • Vsy Biotechnology Gmbh
    • Aptissen SA
    • Mimedx
  • 市場參與企業分類
  • 上市公司
    • 創新者
    • 市場領導者
    • 公司市場分析
    • 協同效應分析：重大交易與策略聯盟
  • 私人公司
    • 私人公司名單
Product Code: GVR-4-68039-477-3

Orthopedic Regenerative Surgical Products Market Growth & Trends

The global orthopedic regenerative surgical products market size is anticipated to reach USD 5.63 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to grow at an attractive CAGR of 4.0% from 2023 to 2030. The primary factors boosting the market growth include the growing older population, easy availability of orthopedic treatments & procedures, and technological advancements. For instance, osteoarthritis, an orthopedic ailment, has been considered the major factor of chronic disability in the geriatric population (aged above 70 years). The product demand was reduced during the COVID-19 pandemic owing to the low volume of patient flow for chronic ailments in hospitals & clinics, abated marketing & sales activities, postponed elective surgeries, social distancing, and lockdown protocols.

For example, Anika Therapeutics notified challenges in patient enrollment for its clinical trials owing to the pandemic, which adversely impacted the company's operating results and revenue. However, the company recovered financial performance and operations as elective surgeries restarted post-pandemic. As per the Centers for Disease Control and Prevention (CDC), approximately 78 million adults in the U.S., or 26% of the population, are projected to be diagnosed with arthritis by 2040. The risk of arthritis increases with age and is found to be more common in females. Another risk factor is obesity. According to the CDC, the prevalence of obesity in the U.S. was estimated to be around 42.4% from 2017 to 2018. Thus, the growing prevalence of orthopedic ailments and the rising aging population & obesity cases are expected to drive market growth. The products used in orthopedic regenerative surgery have a wide range of applications, including gout, joint pain, fibromyalgia, articular defects, osteoarthritis, joint replacement, and trauma.

This is also anticipated to contribute to the growth of the market. Key players in the market are involved in several strategic initiatives, including R&D projects to introduce new regenerative solutions for pain relief from diseases. For instance, in March 2021, Amniox Medical, Inc., received FDA clearance to proceed with a dosing study using its Investigational New Drug (IND) TTAX03- consisting of the umbilical cord and cryopreserved amniotic membrane, to alleviate facet joint osteoarthritis pain. The market participants offer a wide range of orthopedic products; for instance, Zimmer Biomet provides a wide portfolio of synthetic orthopedic regenerative products and allografts, such as the InterGro DBM, PrimaGen Advanced allograft, and PlatFORM bioresorbable bone graft substitute.

Orthopedic Regenerative Surgical Products Market Report Highlights

  • The viscosupplements segment held the largest market share of about 42.59% in 2022 owing to the high prevalence of orthopedic conditions, such as osteoarthritis, and increasing product availability in the market
  • The allografts segment is anticipated to witness a CAGR of 4.1% during the forecast period owing to the increasing utilization of allografts
  • The joint reconstruction segment held the largest revenue share of 35.66% in 2022 in the application segment due to the rising adoption of regenerative solutions in joint reconstruction
  • The cartilage & tendon repair segment is estimated to grow at the fastest CAGR of 4.2% during the forecast period owing to increasing applications in geriatric patients and sports medicine
  • The hospital end-use segment dominated the market and held the largest revenue share of about 49.04% in 2022 as most orthopedic treatments are performed in hospital settings
  • The ambulatory surgical centers (ASCs) segment is expected to showcase the fastest CAGR of 4.1% during the forecast period
  • Key players in the market are undertaking various strategic initiatives, including product development & launches, R&D, regional expansion, and distribution network expansion
  • In January 2021, Stryker acquired OrthoSensor, Inc., a private company that specializes in sensor technology and musculoskeletal care

Table of Contents

Chapter 1 Methodology And Scope

  • 1.1 Market Segmentation And Scope
    • 1.1.1 Segment Scope
    • 1.1.2 Regional Scope
    • 1.1.3 Estimates And Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Research Assumptions
  • 1.4 Information Procurement
    • 1.4.1 Purchased Database
    • 1.4.2 Gvr's Internal Database
    • 1.4.3 Secondary Sources
    • 1.4.4 Primary Research
    • 1.4.5 Details Of Primary Research
  • 1.5 Information Or Data Analysis
    • 1.5.1 Market Formulation & Validation
    • 1.5.2 Data Analysis Models
  • 1.6 Market Formulation & Validation
    • 1.6.1 Primary Validation
  • 1.7 Model Details
    • 1.7.1 Commodity Flow Analysis
  • 1.8 List Of Secondary Sources

Chapter 2 Executive Summary

  • 2.1 Orthopedic Regenerative Surgical Products Market Summary

Chapter 3 Orthopedic Regenerative Surgical Products Market Variables, Trends & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent Market Analysis
    • 3.1.2 Ancillary Market Analysis
  • 3.2 Orthopedic Regenerative Surgical Products Market Dynamics
    • 3.2.1 Market Driver Analysis
    • 3.2.2 Market Restraint Analysis
    • 3.2.3 Market Opportunity Analysis
    • 3.2.4 Market Challenge Analysis
  • 3.3 Penetration And Growth Prospect Mapping,2022
  • 3.4 Swot Analysis, By Factor (Political & Legal, Economic And Technological)
    • 3.4.1 Political & Legal
    • 3.4.2 Economic Landscape
    • 3.4.3 Technology Landscape
  • 3.5 Orthopedic Regenerative Surgical Products Market Analysis Tools: Porters
    • 3.5.1 Bargaining Power Of Suppliers: Low To Moderate
    • 3.5.2 Bargaining Power Of Buyers: Moderate
    • 3.5.3 Threat Of Substitutes: High
  • 3.6 Regulatory Framework
    • 3.6.1 Fda Consideration
    • 3.6.2 Reimbursement Framework
    • 3.6.3 Hcpcs Coding
  • 3.7 Technology Trend Analysis
  • 3.8 Product Pipeline Analysis
  • 3.9 Osteoarthritis Prevalence (2018 to 2030)

Chapter 4 Orthopedic Regenerative Surgical Products Market: COVID-19 Impact Analysis

  • 4.1 COVID-19 Impact Analysis
    • 4.1.1 Disease Prevalence Analysis
    • 4.1.2 Current Impact Analysis
    • 4.1.3 Future Impact Analysis
    • 4.1.4 Impact On Market Players

Chapter 5 Orthopedic Regenerative Surgical Products Market: Segment Analysis, By Product, 2018 - 2030 (USD Million)

  • 5.1 Product Market Share Analysis,2022 & 2030
  • 5.2 Orthopedic Regenerative Surgical Products Market, by Product, 2018 to 2030
  • 5.3 Allograft
    • 5.3.1 Allograft Market, 2018 - 2030 (USD Million)
      • 5.3.1.1 Amniotic Products
      • 5.3.1.1.1 Amniotic Products Market, 2018 - 2030 (USD Million)
    • 5.3.2 Others
      • 5.3.2.1 Others Market, 2018 - 2030 (USD Million)
  • 5.4 Synthetic
    • 5.4.1 Synthetic Market, 2018 - 2030 (USD Million)
  • 5.5 Cell-Based
    • 5.5.1 Cell-Based Market, 2018 - 2030 (USD Million)
  • 5.6 Viscosupplement
    • 5.6.1 Viscosupplement Market, 2018 - 2030 (USD Million)

Chapter 6 Orthopedic Regenerative Surgical Products Market Analysis, By Application, 2018 - 2030 (Revenue, USD Million)

  • 6.1 Application Market Share Analysis,2022 & 2030
  • 6.2 Orthopedic Regenerative Surgical Products Market, By Application, 2018 To 2030
  • 6.3 Orthopedic Pain Management
    • 6.3.1 Orthopedic Pain Management Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.4 Trauma Repair
    • 6.4.1 Trauma Repair Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.5 Cartilage And Tendon Repair
    • 6.5.1 Cartilage And Tendon Repair Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.6 Joint Reconstruction
    • 6.6.1 Joint Reconstruction Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.7 Others
    • 6.7.1 Others Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 7 Orthopedic Regenerative Surgical Products Market: Segment Analysis, By End-Use, 2018 - 2030 (USD Million)

  • 7.1 End-Use Market Share Analysis, 2022 & 2030
  • 7.2 Orthopedic Regenerative Surgical Products Market, By End-Use, 2018 To 2030
  • 7.3 Hospitals
    • 7.3.1 Hospitals Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.4 Ambulatory Surgery Centers
    • 7.4.1 Ambulatory Surgery Center Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5 Others
    • 7.5.1 Others Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 8 Orthopedic Regenerative Surgical Products Market: Regional Market Analysis 2018 - 2030 (USD Million)

  • 8.1 Regional Market Share Analysis, 2022 & 2030
  • 8.2 Regional Market Snapshot
  • 8.3 North America
    • 8.3.1 North America orthopedic regenerative surgical products market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.3.2 U.S.
      • 8.3.2.1 U.S. orthopedic regenerative surgical products market, 2018 - 2030 (USD Million)
    • 8.3.3 Canada
      • 8.3.3.1 Canada Orthopedic Regenerative Surgical Products market, 2018 - 2030 (USD Million)
  • 8.4 Europe
    • 8.4.1 Europe orthopedic regenerative surgical products market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.4.2 UK
      • 8.4.2.1 UK orthopedic regenerative surgical products market, 2018 - 2030 (USD Million)
    • 8.4.3 Germany
      • 8.4.3.1 Germany orthopedic regenerative surgical products market, 2018 - 2030 (USD Million)
    • 8.4.4 France
      • 8.4.4.1 France orthopedic regenerative surgical products market, 2018 - 2030 (USD Million)
    • 8.4.5 Italy
      • 8.4.5.1 Italy orthopedic regenerative surgical products market, 2018 - 2030 (USD Million)
    • 8.4.6 Spain
      • 8.4.6.1 Spain orthopedic regenerative surgical products market, 2018 - 2030 (USD Million)
  • 8.5 Asia Pacific
    • 8.5.1 Asia Pacific orthopedic regenerative surgical products market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.5.2 Japan
      • 8.5.2.1 Japan orthopedic regenerative surgical products market, 2018 - 2030 (USD Million)
    • 8.5.3 China
      • 8.5.3.1 China orthopedic regenerative surgical products market, 2018 - 2030 (USD Million)
    • 8.5.4 India
      • 8.5.4.1 India orthopedic regenerative surgical products market, 2018 - 2030 (USD Million)
    • 8.5.5 Australia
      • 8.5.5.1 Australia orthopedic regenerative surgical products market, 2018 - 2030 (USD Million)
    • 8.5.5 South Korea
      • 8.5.4.1 South Korea orthopedic regenerative surgical products market, 2018 - 2030 (USD Million)
  • 8.6 Latin America
    • 8.6.1 Latin America orthopedic regenerative surgical products market, 2018 - 2030 (USD Million)
    • 8.6.2 Brazil
      • 8.6.2.1 Brazil Orthopedic Regenerative Surgical Products market, 2018 - 2030 (USD Million)
    • 8.6.3 Mexico
      • 8.6.3.1 Mexico orthopedic regenerative surgical products market, 2018 - 2030 (USD Million)
    • 8.6.4 Argentina
      • 8.6.4.1 Argentina Orthopedic Regenerative Surgical Products market, 2018 - 2030 (USD Million)
  • 8.7 MEA
    • 8.7.1 MEA orthopedic regenerative surgical products market, 2018 - 2030 (USD Million)
    • 8.7.2 South Africa
      • 8.7.2.1 South Africa Orthopedic Regenerative Surgical Products market, 2018 - 2030 (USD Million)
    • 8.7.3 Saudi Arabia
      • 8.7.3.1 Saudi Arabia Orthopedic Regenerative Surgical Products market, 2018 - 2030 (USD Million)

Chapter 9 Orthopedic Regenerative Surgical Products Market - Company Profiles

  • 9.1 Company Profiles
    • 9.1.1 Baxter
      • 9.1.1.1 Company Overview
      • 9.1.1.2 Financial Performance
      • 9.1.1.3 Product Benchmarking
      • 9.1.1.4 Strategic Initiatives
    • 9.1.2 Zimmer Biomet
      • 9.1.2.1 Company Overview
      • 9.1.2.2 Financial Performance
      • 9.1.2.3 Product Benchmarking
      • 9.1.2.4 Strategic Initiatives
    • 9.1.3 Stryker
      • 9.1.3.1 Company Overview
      • 9.1.3.2 Financial Performance
      • 9.1.3.3 Product Benchmarking
      • 9.1.3.4 Strategic Initiatives
    • 9.1.4 Smith+Nephew
      • 9.1.4.1 Company Overview
      • 9.1.4.2 Financial Performance
      • 9.1.4.3 Product Benchmarking
      • 9.1.4.4 Strategic Initiatives
    • 9.1.5 Allosource
      • 9.1.5.1 Company Overview
      • 9.1.5.2 Financial Performance
      • 9.1.5.3 Product Benchmarking
      • 9.1.5.4 Strategic Initiatives
    • 9.1.6 Amniox Medical, Inc.
      • 9.1.6.1 Company Overview
      • 9.1.6.2 Financial Performance
      • 9.1.6.3 Product Benchmarking
      • 9.1.6.4 Strategic Initiatives
    • 9.1.7 Anika Therapeutics, Inc.
      • 9.1.7.1 Company Overview
      • 9.1.7.2 Financial Performance
      • 9.1.7.3 Product Benchmarking
      • 9.1.7.4 Strategic Initiatives
    • 9.1.8 Vericel Corporation
      • 9.1.8.1 Company Overview
      • 9.1.8.2 Financial Performance
      • 9.1.8.3 Product Benchmarking
      • 9.1.8.4 Strategic Initiatives
    • 9.1.9 Vsy Biotechnology Gmbh
      • 9.1.9.1 Company Overview
      • 9.1.9.2 Financial Performance
      • 9.1.9.3 Product Benchmarking
      • 9.1.9.4 Strategic Initiatives
    • 9.1.10 Aptissen S.A
      • 9.1.10.1 Company Overview
      • 9.1.10.2 Financial Performance
      • 9.1.10.3 Product Benchmarking
      • 9.1.10.4 Strategic Initiatives
    • 9.1.11 Mimedx
      • 9.1.11.1 Company Overview
      • 9.1.11.2 Financial Performance
      • 9.1.11.3 Product Benchmarking
      • 9.1.11.4 Strategic Initiatives
  • 9.2 Market Participant Categorization
  • 9.3 Public Companies
    • 9.3.1 Innovators
    • 9.3.2 Market Leaders
    • 9.3.3 Company Market Position Analysis
    • 9.3.4 Synergy Analysis: Major Deals & Strategic Alliances
  • 9.4 Private Companies
    • 9.4.1 List Of Private Companies

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of the key regulations, directives by countries
  • Table 3 List of private companies
  • Table 4 North America orthopedic regenerative surgical products market, by product, 2018 - 2030 (USD Million)
  • Table 5 North America orthopedic regenerative surgical products market, by allografts, 2018 - 2030 (USD Million)
  • Table 6 North America orthopedic regenerative surgical products market, by application, 2018 - 2030 (USD Million)
  • Table 7 North America orthopedic regenerative surgical products market, by end use, 2018 - 2030 (USD Million)
  • Table 8 U.S. orthopedic regenerative surgical products market, by product, 2018 - 2030 (USD Million)
  • Table 9 U.S. orthopedic regenerative surgical products market, by allografts, 2018 - 2030 (USD Million)
  • Table 10 U.S. orthopedic regenerative surgical products market, by application, 2018 - 2030 (USD Million)
  • Table 11 U.S. orthopedic regenerative surgical products market, by end use, 2018 - 2030 (USD Million)
  • Table 12 Canada orthopedic regenerative surgical products market, by product, 2018 - 2030 (USD Million)
  • Table 13 Canada orthopedic regenerative surgical products market, by allografts, 2018 - 2030 (USD Million)
  • Table 14 Canada orthopedic regenerative surgical products market, by application, 2018 - 2030 (USD Million)
  • Table 15 Canada orthopedic regenerative surgical products market, by end use, 2018 - 2030 (USD Million)
  • Table 16 Europe orthopedic regenerative surgical products market, by product, 2018 - 2030 (USD Million)
  • Table 17 Europe orthopedic regenerative surgical products market, by allografts, 2018 - 2030 (USD Million)
  • Table 18 Europe orthopedic regenerative surgical products market, by application, 2018 - 2030 (USD Million)
  • Table 19 Europe orthopedic regenerative surgical products market, by end use, 2018 - 2030 (USD Million)
  • Table 20 UK orthopedic regenerative surgical products market, by product, 2018 - 2030 (USD Million)
  • Table 21 UK orthopedic regenerative surgical products market, by allografts, 2018 - 2030 (USD Million)
  • Table 22 UK orthopedic regenerative surgical products market, by application, 2018 - 2030 (USD Million)
  • Table 23 UK orthopedic regenerative surgical products market, by end use, 2018 - 2030 (USD Million)
  • Table 24 Germany orthopedic regenerative surgical products market, by product, 2018 - 2030 (USD Million)
  • Table 25 Germany orthopedic regenerative surgical products market, by allografts, 2018 - 2030 (USD Million)
  • Table 26 Germany orthopedic regenerative surgical products market, by application, 2018 - 2030 (USD Million)
  • Table 27 Germany orthopedic regenerative surgical products market, by end use, 2018 - 2030 (USD Million)
  • Table 28 France orthopedic regenerative surgical products market, by product, 2018 - 2030 (USD Million)
  • Table 29 France orthopedic regenerative surgical products market, by allografts, 2018 - 2030 (USD Million)
  • Table 30 France orthopedic regenerative surgical products market, by application, 2018 - 2030 (USD Million)
  • Table 31 France orthopedic regenerative surgical products market, by end use, 2018 - 2030 (USD Million)
  • Table 32 Italy orthopedic regenerative surgical products market, by product, 2018 - 2030 (USD Million)
  • Table 33 Italy orthopedic regenerative surgical products market, by allografts, 2018 - 2030 (USD Million)
  • Table 34 Italy orthopedic regenerative surgical products market, by application, 2018 - 2030 (USD Million)
  • Table 35 Italy orthopedic regenerative surgical products market, by end use, 2018 - 2030 (USD Million)
  • Table 36 Spain orthopedic regenerative surgical products market, by product, 2018 - 2030 (USD Million)
  • Table 37 Spain orthopedic regenerative surgical products market, by allografts, 2018 - 2030 (USD Million)
  • Table 38 Spain orthopedic regenerative surgical products market, by application, 2018 - 2030 (USD Million)
  • Table 39 Spain orthopedic regenerative surgical products market, by end use, 2018 - 2030 (USD Million)
  • Table 40 Asia Pacific orthopedic regenerative surgical products market, by product, 2018 - 2030 (USD Million)
  • Table 41 Asia Pacific orthopedic regenerative surgical products market, by allografts, 2018 - 2030 (USD Million)
  • Table 42 Asia Pacific orthopedic regenerative surgical products market, by application, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific orthopedic regenerative surgical products market, by end use, 2018 - 2030 (USD Million)
  • Table 44 Japan orthopedic regenerative surgical products market, by product, 2018 - 2030 (USD Million)
  • Table 45 Japan orthopedic regenerative surgical products market, by allografts, 2018 - 2030 (USD Million)
  • Table 46 Japan orthopedic regenerative surgical products market, by application, 2018 - 2030 (USD Million)
  • Table 47 Japan orthopedic regenerative surgical products market, by end use, 2018 - 2030 (USD Million)
  • Table 48 China orthopedic regenerative surgical products market, by product, 2018 - 2030 (USD Million)
  • Table 49 China orthopedic regenerative surgical products market, by allografts, 2018 - 2030 (USD Million)
  • Table 50 China orthopedic regenerative surgical products market, by application, 2018 - 2030 (USD Million)
  • Table 51 China orthopedic regenerative surgical products market, by end use, 2018 - 2030 (USD Million)
  • Table 52 India orthopedic regenerative surgical products market, by product, 2018 - 2030 (USD Million)
  • Table 53 India orthopedic regenerative surgical products market, by allografts, 2018 - 2030 (USD Million)
  • Table 54 India orthopedic regenerative surgical products market, by application, 2018 - 2030 (USD Million)
  • Table 55 India orthopedic regenerative surgical products market, by end use, 2018 - 2030 (USD Million)
  • Table 56 Australia orthopedic regenerative surgical products market, by product, 2018 - 2030 (USD Million)
  • Table 57 Australia orthopedic regenerative surgical products market, by allografts, 2018 - 2030 (USD Million)
  • Table 58 Australia orthopedic regenerative surgical products market, by application, 2018 - 2030 (USD Million)
  • Table 59 Australia orthopedic regenerative surgical products market, by end use, 2018 - 2030 (USD Million)
  • Table 60 South Korea orthopedic regenerative surgical products market, by product, 2018 - 2030 (USD Million)
  • Table 61 South Korea orthopedic regenerative surgical products market, by allografts, 2018 - 2030 (USD Million)
  • Table 62 South Korea orthopedic regenerative surgical products market, by application, 2018 - 2030 (USD Million)
  • Table 63 South Korea orthopedic regenerative surgical products market, by end use, 2018 - 2030 (USD Million)
  • Table 64 Latin America orthopedic regenerative surgical products market, by product, 2018 - 2030 (USD Million)
  • Table 65 Latin America orthopedic regenerative surgical products market, by allografts, 2018 - 2030 (USD Million)
  • Table 66 Latin America orthopedic regenerative surgical products market, by application, 2018 - 2030 (USD Million)
  • Table 67 Latin America orthopedic regenerative surgical products market, by end use, 2018 - 2030 (USD Million)
  • Table 68 Brazil orthopedic regenerative surgical products market, by product, 2018 - 2030 (USD Million)
  • Table 69 Brazil orthopedic regenerative surgical products market, by allografts, 2018 - 2030 (USD Million)
  • Table 70 Brazil orthopedic regenerative surgical products market, by application, 2018 - 2030 (USD Million)
  • Table 71 Brazil orthopedic regenerative surgical products market, by end use, 2018 - 2030 (USD Million)
  • Table 72 Mexico orthopedic regenerative surgical products market, by product, 2018 - 2030 (USD Million)
  • Table 73 Mexico orthopedic regenerative surgical products market, by allografts, 2018 - 2030 (USD Million)
  • Table 74 Mexico orthopedic regenerative surgical products market, by application, 2018 - 2030 (USD Million)
  • Table 75 Mexico orthopedic regenerative surgical products market, by end use, 2018 - 2030 (USD Million)
  • Table 76 Argentina orthopedic regenerative surgical products market, by product, 2018 - 2030 (USD Million)
  • Table 77 Argentina orthopedic regenerative surgical products market, by allografts, 2018 - 2030 (USD Million)
  • Table 78 Argentina orthopedic regenerative surgical products market, by application, 2018 - 2030 (USD Million)
  • Table 79 Argentina orthopedic regenerative surgical products market, by end use, 2018 - 2030 (USD Million)
  • Table 80 MEA orthopedic regenerative surgical products market, by product, 2018 - 2030 (USD Million)
  • Table 81 MEA orthopedic regenerative surgical products market, by allografts, 2018 - 2030 (USD Million)
  • Table 82 MEA orthopedic regenerative surgical products market, by application, 2018 - 2030 (USD Million)
  • Table 83 MEA orthopedic regenerative surgical products market, by end use, 2018 - 2030 (USD Million)
  • Table 84 South Africa orthopedic regenerative surgical products market, by component, 2018 - 2030 (USD Million)
  • Table 85 South Africa orthopedic regenerative surgical products market, by product, 2018 - 2030 (USD Million)
  • Table 86 South Africa orthopedic regenerative surgical products market, by allografts, 2018 - 2030 (USD Million)
  • Table 87 South Africa orthopedic regenerative surgical products market, by application, 2018 - 2030 (USD Million)
  • Table 88 South Africa orthopedic regenerative surgical products market, by end use, 2018 - 2030 (USD Million)
  • Table 89 Saudi Arabia orthopedic regenerative surgical products market, by product, 2018 - 2030 (USD Million)
  • Table 90 Saudi Arabia orthopedic regenerative surgical products market, by allografts, 2018 - 2030 (USD Million)
  • Table 91 Saudi Arabia orthopedic regenerative surgical products market, by application, 2018 - 2030 (USD Million)
  • Table 92 Saudi Arabia orthopedic regenerative surgical products market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Orthopedic Regenerative Surgical Products market segmentation
  • Fig. 2 Methodology
  • Fig. 3 Market research process
  • Fig. 4 Data triangulation techniques
  • Fig. 5 Primary research pattern
  • Fig. 6 Primary research pattern
  • Fig. 7 Market research approaches
  • Fig. 8 Value-chain-based sizing & forecasting
  • Fig. 9 QFD modeling for market share assessment
  • Fig. 10 Market formulation & validation
  • Fig. 11 Orthopedic Regenerative Surgical Products Market outlook (2022, USD Million)
  • Fig. 12 Parent market analysis
  • Fig. 13 Ancillary market analysis
  • Fig. 14 Orthopedic regenerative surgical products market dynamics analysis
  • Fig. 15 Orthopedic regenerative surgical products market driver analysis
  • Fig. 16 Common causes of spinal injury, 2018
  • Fig. 17 Orthopedic regenerative surgical products market restraint impact
  • Fig. 18 Penetration & growth prospect mapping by end-use, 2022
  • Fig. 19 Ortho regenerative technologies: Product pipeline analysis
  • Fig. 20 COVID-19 confirmed cases around the world
  • Fig. 21 Orthopedic Regenerative Surgical Products market: Product movement analysis
  • Fig. 22 Orthopedic Regenerative Surgical Products market product outlook: Key takeaways
  • Fig. 23 Allograft market, 2018 - 2030 (USD Million)
  • Fig. 24 Amniotic products market, 2018 - 2030 (USD Million)
  • Fig. 25 Others market, 2018 - 2030 (USD Million)
  • Fig. 26 Synthetic market, 2018 - 2030 (USD Million)
  • Fig. 27 Cell-based market, 2018 - 2030 (USD Million)
  • Fig. 28 Viscosupplement market, 2018 - 2030 (USD Million)
  • Fig. 29 Orthopedic Regenerative Surgical Products market: Application movement analysis
  • Fig. 30 Orthopedic Regenerative Surgical Products market application outlook: Key takeaways
  • Fig. 31 Global orthopedic pain management market, 2018 - 2030 (USD Million)
  • Fig. 32 Global trauma market, 2018 - 2030 (USD Million)
  • Fig. 33 Global cartilage and tendon repair market, 2018 - 2030 (USD Million)
  • Fig. 34 Global joint reconstruction market, 2018 - 2030 (USD million)
  • Fig. 35 Global others market, 2018 - 2030 (USD Million)
  • Fig. 36 Orthopedic Regenerative Surgical Products market: End-use movement analysis
  • Fig. 37 Orthopedic Regenerative Surgical Products market end-use outlook: Key takeaways
  • Fig. 38 Global hospitals market, 2018 - 2030 (USD Million)
  • Fig. 39 Global ambulatory surgery center market, 2018 - 2030 (USD Million)
  • Fig. 40 Global others market, 2018 - 2030 (USD Million)
  • Fig. 41 Regional outlook, 2022 & 2030
  • Fig. 42 Regional marketplace: Key takeaways
  • Fig. 43 North America orthopedic regenerative surgical products market, 2018 - 2030 (USD Million)
  • Fig. 44 U.S. orthopedic regenerative surgical products market, 2018 - 2030 (USD Million)
  • Fig. 45 Canada Orthopedic Regenerative Surgical Products market, 2018 - 2030 (USD Million)
  • Fig. 46 Europe orthopedic regenerative surgical products market, 2018 - 2030 (USD Million)
  • Fig. 47 UK orthopedic regenerative surgical products market, 2018 - 2030 (USD Million)
  • Fig. 48 Germany orthopedic regenerative surgical products market, 2018 - 2030 (USD Million)
  • Fig. 49 France orthopedic regenerative surgical products market, 2018 - 2030 (USD Million)
  • Fig. 50 Italy orthopedic regenerative surgical products market, 2018 - 2030 (USD Million)
  • Fig. 51 Spain orthopedic regenerative surgical products market, 2018 - 2030 (USD Million)
  • Fig. 52 Asia Pacific orthopedic regenerative surgical products market, 2018 - 2030 (USD Million)
  • Fig. 53 Japan orthopedic regenerative surgical products market, 2018 - 2030 (USD Million)
  • Fig. 54 China orthopedic regenerative surgical products market, 2018 - 2030 (USD Million)
  • Fig. 55 India orthopedic regenerative surgical products market, 2018 - 2030 (USD Million)
  • Fig. 56 Australia orthopedic regenerative surgical products market, 2018 - 2030 (USD Million)
  • Fig. 57 South Korea orthopedic regenerative surgical products market, 2018 - 2030 (USD Million)
  • Fig. 58 Latin America Orthopedic Regenerative Surgical Products market, 2018 - 2030 (USD Million)
  • Fig. 59 Brazil Orthopedic Regenerative Surgical Products market, 2018 - 2030 (USD Million)
  • Fig. 60 Mexico Orthopedic Regenerative Surgical Products market, 2018 - 2030 (USD Million)
  • Fig. 61 Argentina Orthopedic Regenerative Surgical Products market, 2018 - 2030 (USD Million)
  • Fig. 62 MEA Orthopedic Regenerative Surgical Products market, 2018 - 2030 (USD Million)
  • Fig. 63 South Africa Orthopedic Regenerative Surgical Products market, 2018 - 2030 (USD Million)
  • Fig. 64 Saudi Arabia Orthopedic Regenerative Surgical Products market, 2018 - 2030 (USD Million)
  • Fig. 65 Market participant categorization
  • Fig. 66 Orthopedic regenerative surgical products: Company market position analysis
  • Fig. 67 Strategy mapping